Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…Objectives Pulmonary diseases (PD) in Systemic Lupus Erythematosus (SLE) have received little attention despite it being prevalent…
…Objectives Patients (pts) with systemic lupus erythematosus (SLE) have a significantly increased risk of atherosclerotic ca…
…ctives Rituximab (RTX) is an established therapy for refractory Systemic Lupus Erythematosus (SLE), but its use raises concerns about infection risk and hyp…
…ab is increasingly becoming an important therapeutic option for systemic lupus erythematosus (SLE), but evidence points to a heightened risk of varicella-zo…
…AD), potentially mitigating progression to symptomatic disease. Systemic lupus erythematosus (SLE) has an increased risk of accelerated atherosclerotic CAD.…
…Objectives Type I-III interferons (IFNs) are key mediators in systemic lupus erythematosus (SLE) and have been proposed to contribute to cardiovascular di…
…ere pulmonary hypertension (PH) as the initial manifestation of systemic lupus erythematosus (SLE).Methods Case report A 21-year-old woman, with a family hi…
…clinical factors associated with atherosclerosis progression in Systemic Lupus Erythematosus (SLE)Methods Sixty-nine patients with SLE underwent ultrasound …
… among the most frequent and clinically significant features of systemic lupus erythematosus (SLE), occurring in approximately 70–85% of patients during the…
…mental health problems are a major concern for individuals with systemic lupus erythematosus (SLE). Although anxiety and depression are frequently reported,…
…Objectives We examined the association between organ damage in systemic lupus erythematosus (SLE) and different patterns of glucocorticoid (GC) dosing.Meth…
… identify a subgroup at increased risk of developing associated Sjögren’s Disease. Prospective studies are needed to explore this hypothesis.…